1. Home
  2. OBT vs IVA Comparison

OBT vs IVA Comparison

Compare OBT & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OBT
  • IVA
  • Stock Information
  • Founded
  • OBT 1892
  • IVA 2011
  • Country
  • OBT United States
  • IVA France
  • Employees
  • OBT N/A
  • IVA N/A
  • Industry
  • OBT Major Banks
  • IVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • OBT Finance
  • IVA Health Care
  • Exchange
  • OBT Nasdaq
  • IVA Nasdaq
  • Market Cap
  • OBT 368.1M
  • IVA 359.6M
  • IPO Year
  • OBT N/A
  • IVA 2020
  • Fundamental
  • Price
  • OBT $26.45
  • IVA $4.46
  • Analyst Decision
  • OBT Buy
  • IVA Strong Buy
  • Analyst Count
  • OBT 1
  • IVA 4
  • Target Price
  • OBT $29.00
  • IVA $10.50
  • AVG Volume (30 Days)
  • OBT 32.5K
  • IVA 31.1K
  • Earning Date
  • OBT 07-30-2025
  • IVA 09-24-2025
  • Dividend Yield
  • OBT 1.98%
  • IVA N/A
  • EPS Growth
  • OBT N/A
  • IVA N/A
  • EPS
  • OBT 2.57
  • IVA N/A
  • Revenue
  • OBT $105,510,000.00
  • IVA $14,591,573.00
  • Revenue This Year
  • OBT $18.39
  • IVA $44.22
  • Revenue Next Year
  • OBT $7.98
  • IVA $24.23
  • P/E Ratio
  • OBT $10.22
  • IVA N/A
  • Revenue Growth
  • OBT 2.48
  • IVA N/A
  • 52 Week Low
  • OBT $20.97
  • IVA $1.53
  • 52 Week High
  • OBT $33.06
  • IVA $4.70
  • Technical
  • Relative Strength Index (RSI)
  • OBT 59.93
  • IVA 65.97
  • Support Level
  • OBT $23.96
  • IVA $4.11
  • Resistance Level
  • OBT $25.49
  • IVA $4.70
  • Average True Range (ATR)
  • OBT 0.77
  • IVA 0.30
  • MACD
  • OBT 0.22
  • IVA 0.08
  • Stochastic Oscillator
  • OBT 98.58
  • IVA 84.42

About OBT Orange County Bancorp Inc.

Orange County Bancorp Inc provides banking services. Its services include personal banking services such as personal loans, personal savings, business loans, business savings, and Internet banking among others. The company provides commercial and consumer banking services to individuals, small businesses, and local municipal governments as well as trust and investment services through the Bank and HVIA. Its segment includes banking and wealth management. The company generates maximum revenue from the banking segment.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: